Adiposity is associated with expansion of the genus Dialister in rheumatoid arthritis patients

Abstract

Objective: To analyze the intestinal microbiota of patients with rheumatoid arthritis (RA) and obesity and a higher percentage of fatty tissue. Methods: Nested case-control study of 80 RA patients and 80 age and sex-matched controls. Obesity was defined as a body mass index ≥ 30, and body composition using dual-energy x-ray absorptiometry. The gut microbiota was analyzed using 16 S rRNA gene sequencing; bioinformatics analysis was performed using QIIME2 and PICRUSt. Other variables included averaged 28-joint Disease Activity Score (DAS28-ESR), cytokines and adipokines. Two multivariate were constructed with obesity and fat mass index (FMI). Results: Obesity was more frequent in RA patients than in controls (36.3 % vs 25.1 %; p = 0.026), as was a higher FMI value (mean [SE]=11.6 [3.9] vs 10.2 [3.9]; p = 0.032). Alpha and beta diversity analysis revealed differences in gut microbiota between RA patients with and without obesity. Dialister and Odoribacter were more abundant in RA patients with obesity than in RA patients without obesity, while the genus Clostridium was more abundant in RA patients without obesity. The factors associated with obesity in RA patients were age (OR [95 % CI], 1.09 [1.02–1.17]), mean DAS28-ESR (OR [95 % CI], 1.46 [1.12–1.67]), leptin levels (OR [95 % CI], 1.06 [1.01–1.10]), the genus Dialister (OR [95 % CI], 1.03 [1.01–1.07]), and the genus Clostridium (OR [95 % CI], 0.013 [0.00–0.36]). The associations observed for FMI were similar. Conclusions: In patients with RA, obesity, and a higher percentage of fatty tissue, intestinal microbiota differed from that of controls and of the other patients. The genus Dialister was associated with obesity and FMI.

Keywords

• Rheumatoid arthritis
• Gut microbiota
• Obesity
• Adiposity
• Body composition
• Inflammation